Alloimmune neonatal neutropenia treated with rHuG-CSF

Pediatr Med Chir. 1999 Jan-Feb;21(1):27-8.

Abstract

Infants with alloimmune neonatal neutropenia (ANN) may be at risk of life-threatening infection. Various modalities of treatment have been attempted but with differing results. We describe a case treated with rHuG-CSF. The use of rHuG-CSF should be considered in children with ANN especially when associated with life-threatening infection.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Cell Growth Factors / therapeutic use*
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / drug therapy
  • Infant, Newborn, Diseases / immunology*
  • Neutropenia / drug therapy
  • Neutropenia / immunology*
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Hematopoietic Cell Growth Factors
  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor